JP Morgan Chase
OCRX

JP Morgan Chase’s Ocera Therapeutics, Inc. OCRX Stock Holding History

JP Morgan Chase’s Portfolio OCRX Stock Details OCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-400
Closed -$1K – 5261
2016
Q3 		$1K Buy
+400
New +$999 ﹤0.01% 4493
2015
Q3 		– Sell
-72,467
Closed -$275K – 4210
2015
Q2 		$275K Buy
72,467
+23,933
+49% +$91.8K ﹤0.01% 3746
2015
Q1 		$229K Sell
48,534
-13,817
-22% -$79.6K ﹤0.01% 3786
2014
Q4 		$397K Buy
+62,351
New +$365K ﹤0.01% 3765

Other funds holding OCRX

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

JP Morgan Chase's OCRX Position: Q4 2016 in Review

JP Morgan Chase sold out of Ocera Therapeutics, Inc. (OCRX) in Q4 2016, closing a stake of 400 shares — an estimated $1K sold.

JP Morgan Chase first reported a position in OCRX in Q4 2014 and held it in 4 quarters. The position peaked at $397K in Q4 2014. 36 funds tracked by Wall St. Rank hold OCRX as of Q4 2016.

  • JP Morgan Chase reported no remaining Ocera Therapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
  • JP Morgan Chase sold 400 Ocera Therapeutics, Inc. shares in Q4 2016, an estimated $1K.
  • JP Morgan Chase first reported a position in Ocera Therapeutics, Inc. in Q4 2014 and held it in 4 quarters.
  • JP Morgan Chase's Ocera Therapeutics, Inc. position peaked at $397K in Q4 2014.
  • 36 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q4 2016.

Based on JP Morgan Chase's 13F filing for Q4 2016, filed 6 Feb 2017.